James P. Kelly

2020 - Supernus Pharmaceuticals

In 2020, James P. Kelly earned a total compensation of $1.8M as Executive Vice President, Chief Financial Officer at Supernus Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$50,900
Option Awards$1,641,727
Salary$102,910
Other$6,099
Total$1,801,636

Kelly received $1.6M in option awards, accounting for 91% of the total pay in 2020.

Kelly also received $50.9K in non-equity incentive plan, $102.9K in salary and $6.1K in other compensation.

Rankings

In 2020, James P. Kelly's compensation ranked 6,009th out of 13,090 executives tracked by ExecPay. In other words, Kelly earned more than 54.1% of executives.

ClassificationRankingPercentile
All
6,009
out of 13,090
54th
Division
Manufacturing
2,477
out of 5,621
56th
Major group
Chemicals And Allied Products
992
out of 2,254
56th
Industry group
Drugs
858
out of 1,954
56th
Industry
Pharmaceutical Preparations
638
out of 1,459
56th

Pay ratio

James P. Kelly's Pay$1,801,636
Median Employee's Pay$148,804
Pay Ratio

12

to 1

In 2020, the annual total compensation of James P. Kelly was $1,801,636.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.

The ratio of James P. Kelly's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on April 30, 2021.

Kelly's colleagues

We found five more compensation records of executives who worked with James P. Kelly at Supernus Pharmaceuticals in 2020.

2020

Jack Khattar

Supernus Pharmaceuticals

Chief Executive Officer

2020

Stefan Schwabe

Supernus Pharmaceuticals

Chief Medical Officer

2020

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2020

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

2020

Tami RN

Supernus Pharmaceuticals

Senior Vice President, Regulatory Affairs

News

In-depth

You may also like